Biogeny Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 16-12-2024
- Paid Up Capital ₹ 3.01 M
as on 16-12-2024
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.48 Cr
as on 16-12-2024
- Revenue 90.07%
(FY 2022)
- Profit 522.34%
(FY 2022)
- Ebitda 393.14%
(FY 2022)
- Net Worth 82.30%
(FY 2022)
- Total Assets 104.37%
(FY 2022)
About Biogeny Diagnostics
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.01 M.
The company currently has active open charges totaling ₹2.48 Cr.
Dineshchandra Joshi, Bruno Pizzochero, and Jignesh Patel serve as directors at the Company.
- CIN/LLPIN
U24299GJ2009PTC057520
- Company No.
057520
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jul 2009
- Date of AGM
09 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Navsari, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biogeny Diagnostics Private Limited offer?
Biogeny Diagnostics Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Clinical Reagents, Analyzers & Analytical Instruments, Elemental Analyzer.
Who are the key members and board of directors at Biogeny Diagnostics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jignesh Patel  | Director | 23-Sep-2009 | Current |
| Dineshchandra Joshi | Director | 01-Apr-2018 | Current |
Bruno Pizzochero  | Director | 13-Jul-2009 | Current |
Financial Performance and Corporate Structure Insights of Biogeny Diagnostics.
Biogeny Diagnostics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 90.07% increase. The company also saw a substantial improvement in profitability, with a 522.34% increase in profit. The company's net worth Soared by an impressive increase of 82.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biogeny Diagnostics?
Unlock access to Biogeny Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Mar 2023 | ₹1.25 M | Open |
Others Creation Date: 21 Apr 2010 | ₹2.35 Cr | Open |
How Many Employees Work at Biogeny Diagnostics?
Biogeny Diagnostics has a workforce of 76 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biogeny Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biogeny Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
